Skip to main content

Table 3 Prevalence (%) and 95% confidence intervals (CI) of multisite musculoskeletal symptoms (MS) lasting at least 30 days during the past 12 months among men and women

From: Prevalence of multisite musculoskeletal symptoms: a French cross-sectional working population-based study

Multisite MS: n (%) CI Men (N = 2,162) Women (N = 1,548)
By genre** 370 (17.1) 15.5-18.7 346 (22.4) 20.3-24.4
By age group (test for linear trend) §§‡
16-29 years 48 (9.3) 6.8-11.9 43 (11.9) 8.6-15.3
30-39 years 97 (14.9) 12.2-17.7 72 (16.8) 13.2-20.3
40-49 years 130 (21.2) 18.0-24.5 132 (27.1) 23.2-31.1
50-63 years 93 (24.5) 20.2-28.9 99 (36.7) 30.9-42.4
By occupational category§
Managers and professionals 22 (10.5) 6.3-14.6 19 (24.4) 14.8-33.9
Associate professionals/technicians 86 (15.9) 12.8-19.0 54 (18.7) 14.2-23.2
Employees 30 (16.0) 10.7-21.2 170 (21.3) 18.5-24.1
Skilled and unskilled workers 232 (19.2) 17.0-21.4 102 (27.1) 22.6-31.5
By economic activity
Service industries 170 (15.8) 13.6-17.9 228 (20.9) 18.5-23.3
Meat and manufacturing industries 160 (18.6) 16.0-21.2 108 (27.0) 22.6-31.3
Construction 34 (18.0) 12.5-23.5 2 (8.0) 1.0-26.0#
Agriculture 5 (16.1) 3.2-29.1 6 (24.0) 7.3-40.7
  1. Significant differences between men and women: * p < 0.01, ** p < 0.0001.
  2. Significant differences among men: § p < 0.01, §§ p < 0.0001.
  3. Significant differences among women: p < 0.01, p < 0.0001.
  4. # Estimation of CI with Fisher’s exact method (np or nq < 5).